Matthew T. Roe

1996–2025 年に発表

別表記
Matthew T Roe
177
論文数
33,827
被引用数
103
h 指数
176
i10 指数

被引用数

Matthew T. Roe の年別被引用数1952 年: 被引用 1 件1969 年: 被引用 1 件1995 年: 被引用 2 件1996 年: 被引用 1 件1997 年: 被引用 1 件1998 年: 被引用 4 件1999 年: 被引用 4 件2000 年: 被引用 8 件2001 年: 被引用 13 件2002 年: 被引用 23 件2003 年: 被引用 29 件2004 年: 被引用 30 件2005 年: 被引用 65 件2006 年: 被引用 67 件2007 年: 被引用 131 件2008 年: 被引用 110 件2009 年: 被引用 135 件2010 年: 被引用 158 件2011 年: 被引用 237 件2012 年: 被引用 216 件2013 年: 被引用 222 件2014 年: 被引用 259 件2015 年: 被引用 211 件2016 年: 被引用 190 件2017 年: 被引用 186 件2018 年: 被引用 201 件2019 年: 被引用 1,024 件2020 年: 被引用 1,201 件2021 年: 被引用 1,058 件2022 年: 被引用 896 件2023 年: 被引用 663 件2024 年: 被引用 1,171 件2025 年: 被引用 532 件2026 年: 被引用 41 件1953〜1968 年は被引用が無いため表示していません1970〜1994 年は被引用が無いため表示していません

引用元

国・地域

この著者を引用した国・地域の世界地図アメリカ合衆国: 引用元論文 3,484 件、この内訳の 23.8%イギリス: 引用元論文 1,181 件、この内訳の 8.1%カナダ: 引用元論文 854 件、この内訳の 5.8%イタリア: 引用元論文 802 件、この内訳の 5.5%中国: 引用元論文 727 件、この内訳の 5%ドイツ: 引用元論文 692 件、この内訳の 4.7%フランス: 引用元論文 515 件、この内訳の 3.5%オランダ: 引用元論文 492 件、この内訳の 3.4%オーストラリア: 引用元論文 475 件、この内訳の 3.2%スペイン: 引用元論文 408 件、この内訳の 2.8%スウェーデン: 引用元論文 316 件、この内訳の 2.2%日本: 引用元論文 304 件、この内訳の 2.1%
0%23.8%その他 29.9%

分野

  • Medicine86.4%
  • Biochemistry, Genetics and Molecular Biology3.8%
  • Health Professions2.6%
  • Engineering1.7%
  • Economics, Econometrics and Finance1.2%
  • Computer Science1.1%
  • その他3.2%

トピック

  • Lipoproteins and Cardiovascular Health8.2%
  • Acute Myocardial Infarction Research7.8%
  • Coronary Interventions and Diagnostics4.5%
  • Diabetes Treatment and Management4.4%
  • Cardiac Imaging and Diagnostics4.1%
  • Antiplatelet Therapy and Cardiovascular Diseases3.9%
  • その他67.1%

共著者

全論文

検索で開く
  1. Alirocumab and Cardiovascular Outcomes after Acute Coronary Syndrome

    著者: , , , , , , , , , , , , , , , , , , , , , - New England Journal of Medicine 2018 被引用: 3,519

  2. Albiglutide and cardiovascular outcomes in patients with type 2 diabetes and cardiovascular disease (Harmony Outcomes): a double-blind, randomised placebo-controlled trial

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , David C. M. Kong, Gerald S. Bloomfield, Matthew T. Roe, Pierluigi Tricoci, Robert W. Harrison, Renato D. Lópes, Robin Mathews, Rajendra Mehta, W. Schuyler Jones, Sreekanth Vemulapalli, Thomas J. Povsic, Zubin J. Eapen, Keith Dombrowski, Brad J. Kolls, J. Dedrick Jordan, Andrew P. Ambrosy, Stephen J. Greene, Aditya Mandawat, Jay Shavadia, Lauren B. Cooper, Abhinav Sharma, Patrícia O. Guimarães, Daniel J. Friedman, Matthew E. Wilson, Patricia Endsley, Tracy Gentry, Jeannie Collier, Kathleen Perez, K.E. James, Jennifer Roush, C. ARDEN III POPE, Christina Howell, Megan Johnson, M. Bailey, Joanna Cole, Teresa Akers, Beth Vandyne, Betsy Thomas, Jenny Rich, Susan Bartone, Gail Beaulieu, Kim Brown, Tuan Chau, Tamra Christian, Rebecca Coker, Deb Greene, Trevorlyn Haddock, Wendy Jenkins, Ghazala Haque, Marsha L. Marquess, Jean Pesarchick, Renee Rethaford, Allegra Stone, Firas Al- Kawas, Michelle A. Anderson, Robert Enns, Isaac Sinay, Chantal Mathieu, Victor Yordanov, Irene Hramiak, Martin Haluzı́k, Søren Galatius, Bruno Guerci, Michael A. Nauck, Ilias Migdalis, Choon Beng Kathryn Tan, Győző Kocsis, Andrea Giaccari, Moon Kyu Lee, Ernesto Muñoz ほか 708 名 - The Lancet 2018 被引用: 1,791

  3. Effect of Alirocumab on Lipoprotein(a) and Cardiovascular Risk After Acute Coronary Syndrome

    著者: , , , , , , , , , , , , , , , , , , , , , , , , - Journal of the American College of Cardiology 2020 被引用: 572

  4. The role of machine learning in clinical research: transforming the future of evidence generation

    著者: , , , , , , , , , , , , , , , , , , , , - Trials 2021 被引用: 282

  5. Using Digital Health Technology to Better Generate Evidence and Deliver Evidence-Based Care

    著者: , , , , , , , , , , , , , , , , - Journal of the American College of Cardiology 2018 被引用: 344

  6. Effects of alirocumab on cardiovascular and metabolic outcomes after acute coronary syndrome in patients with or without diabetes: a prespecified analysis of the ODYSSEY OUTCOMES randomised controlled trial

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Robert A. Harrington, J. Wouter Jukema, Michael Szarek, Harvey D. White, Andreas M. Zeiher, Pierluigi Tricoci, Matthew T. Roe, Kenneth W. Mahaffey, Jay M. Edelberg, Corinne Hanotin, Guillaume Lecorps, Angèle Moryusef, Robert Pordy, William J. Sasiela, Jean‐François Tamby, Philip E. Aylward, Heinz Drexel, Peter Sinnaeve, Mirza Dilić, Renato D. Lópes, Nina Gotcheva, Juan Carlos Prieto, Yong Huo, Patricio López‐Jaramillo, Ivan Pećin, Željko Reiner, Petr Ostadal, Margus Viigimaa, Markku S. Nieminen, Vakhtang Chumburidze, Nikolaus Marx, Nicolas Danchin, Evangelos Liberopoulos, Pablo Carlos Montenegro Valdovinos, Hung‐Fat Tse, Róbert Gábor Kiss, Denis Xavier, Doron Zahger, Marco Valgimigli, Takeshi Kimura, Hyo Soo Kim, Sang‐Hyun Kim, Andrejs Ērglis, Aleksandras Laucevičius, Saško Kedev, K. Yusoff, Gabriel Arturo Ramos López, Marco Alings, Sigrun Halvorsen, Roger M. Correa Flores, Andrzej Budaj, Joao Morais, Maria Dorobantu, Yuri Karpov, Arsen Ristić, Terrance Chua, Jan Murin, Zlatko Fras, Anthony J. Dalby, José Tuñón, H Asita de Silva, Emil Hagström, Ulf Landmesser, Chern‐En Chiang, Piyamitr Sritara, Sema Güneri, Alexander Parkhomenko, Kausik K. Ray, Patrick M. Moriarty, Robert A. Vogel ほか 1,603 名 - The Lancet Diabetes & Endocrinology 2019 被引用: 328

  7. Peripheral Artery Disease and Venous Thromboembolic Events After Acute Coronary Syndrome

    著者: , , , , , , , , , , , - Circulation 2020 被引用: 187

  8. Comparative Effectiveness of Aspirin Dosing in Cardiovascular Disease

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Tamar S. Polonsky, Dan J. Fintel, Faraz S. Ahmad, James C. McClay, James R. Campbell, Douglas S. Bell, Gregg C. Fonarow, Steven M. Bradley, Anuradha Paranjape, Matthew T. Roe, Holly R. Robertson, Lesley H. Curtis, Amber Sharlow, Lisa G. Berdan, Bradley G. Hammill, Debra F. Harris, Laura G. Qualls, Guillaume Marquis‐Gravel, Madelaine Faulkner Modrow, Gregory M. Marcus, Thomas W. Carton, Elizabeth Nauman, Lemuel R. Waitman, Abel Kho, Elizabeth Shenkman, Kathleen M. McTigue, Rainu Kaushal, Frederick A. Masoudi, Elliott M. Antman, Desiree R. Davidson, Kevin Edgley, J. Greg Merritt, Linda S. Brown, Doris N. Zemon, Thomas E. McCormick, Jacqueline D. Alikhaani, Kenneth C. Gregoire, Russell L. Rothman, Robert A. Harrington, Adrian F. Hernandez - New England Journal of Medicine 2021 被引用: 307

  9. Lipoprotein(a) and Benefit of PCSK9 Inhibition in Patients With Nominally Controlled LDL Cholesterol

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Jay M. Edelberg, Corinne Hanotin, Guillaume Lecorps, Angèle Moryusef, Robert Pordy, William J. Sasiela, Jean‐François Tamby, Rafael Diaz, Philip E. Aylward, Heinz Drexel, Peter Sinnaeve, Mirza Dilić, Renato D. Lopes, Nina Gotcheva, Shaun G. Goodman, Juan-Carlos Prieto, Yong Huo, Patricio López‐Jaramillo, Ivan Pećin, Zeljko Reiner, Petr Ošťádal, Steen Hvitfeldt Poulsen, Margus Viigimaa, Markku S. Nieminen, Nicolas Danchin, Vakhtang Chumburidze, Nikolaus Marx, Evangelos Liberopoulos, Pablo Carlos Montenegro Valdovinos, Hung-Fat Tse, Róbert Gábor Kiss, Denis Xavier, Doron Zahger, Marco Valgimigli, Takeshi Kimura, Hyo Soo Kim, Sang-Hyun Kim, Andrejs Ērglis, Aleksandras Laucevičius, Saško Kedev, Khalid Yusoff, Gabriel Arturo Ramos López, Marco Alings, Harvey D. White, Sigrun Halvorsen, Roger M. Correa Flores, Rody G. Sy, Andrzej Budaj, Joao Morais, Maria Dorobantu, Yuri Karpov, Arsen D. Ristic, Terrance Chua, Jan Murin, Zlatko Fras, Anthony J. Dalby, José Tuñón, H. Asita de Silva, Emil Hagström, Ulf Landmesser, Christian Müller, Chern‐En Chiang, Piyamitr Sritara, Sema Güneri, Alexander Parkhomenko, Kausik K. Ray, Patrick M. Moriarty, Matthew T. Roe, Robert A. Vogel, Bernard Chaitman ほか 1,652 名 - Journal of the American College of Cardiology 2021 被引用: 141

  10. Apolipoprotein B, Residual Cardiovascular Risk After Acute Coronary Syndrome, and Effects of Alirocumab

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Matthew T. Roe, Kenneth W. Mahaffey, Jay M. Edelberg, Corinne Hanotin, Guillaume Lecorps, Angèle Moryusef, Robert Pordy, William J. Sasiela, Jean‐François Tamby, Rafael Díaz, Philip E Aylward, Heinz Drexel, Peter Sinnaeve, Mirza Dilić, Renato D. Lópes, Nina N Gotcheva, Shaun G. Goodman, Juan Carlos Prieto, Huo Yong, Patricio López‐Jaramillo, Ivan Pećin, Zeljko Reiner, Petr Ostadal, Steen Hvitfeldt Poulsen, Margus Viigimaa, Markku S. Nieminen, Nicolas Danchin, Vakhtang Chumburidze, Nikolaus Marx, Evangelos Liberopoulos, Pablo Carlos, Montenegro Valdovinos, Hung‐Fat Tse, Róbert Gábor Kiss, Denis Xavier, Doron Zahger, Marco Valgimigli, Takeshi Kimura, Hyo-Soo Kim, Sang‐Hyun Kim, Andrejs Ērglis, Aleksandras Laucevičius, Saško Kedev, Khalid Yusoff, Gabriel Arturo Ramos López, Marco Alings, Harvey D. White, Sigrun Halvorsen, Roger M Correa Flores, Rody G. Sy, Andrzej Budaj, João Morais, Maria Dorobantu, Yuri Karpov, Arsen Ristić, Terrance Chua, Ján Murín, Zlatko Fras, Anthony J. Dalby, José Tuñón, H. Asita de Silva, Emil Hagström, Ulf Landmesser, Christian Müller, Chern‐En Chiang, Piyamitr Sritara, Sema Güneri, Alexander Parkhomenko, Kausik K. Ray, Patrick M. Moriarty ほか 1,635 名 - Circulation 2022 被引用: 122

  11. Mortality of Myocardial Infarction by Sex, Age, and Obstructive Coronary Artery Disease Status in the ACTION Registry–GWTG (Acute Coronary Treatment and Intervention Outcomes Network Registry–Get With the Guidelines)

    著者: , , , , , , - Circulation Cardiovascular Quality and Outcomes 2017 被引用: 343

  12. Alirocumab in Patients With Polyvascular Disease and Recent Acute Coronary Syndrome

    著者: , , , , , , , , , , , , , , , , , , , - Journal of the American College of Cardiology 2019 被引用: 237

  13. Cardiovascular Safety of Degarelix Versus Leuprolide in Patients With Prostate Cancer: The Primary Results of the PRONOUNCE Randomized Trial

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Thomas J. Povsic, Michael Morse, Kenneth W. Mahaffey, Susan Halabi, Darryl P. Leong, Laurence Klotz, Neil Fleshner, G. Kenneth Jansz, Jonathan Giddens, R. Blair Egerdie, Joseph L. Chin, Joseph Zadra, Richard Casey, Jean Simard, Tamim Niazi, André‐Guy Martin, Marek Babjuk, Jaroslav Hájek, Jiří Klečka, Jiří Kubeš, Jan Schraml, Jitka Jakesova, J Vaňásek, Bohuslav Melichar, Heikki Seikkula, M. Abdiche, Marc Colombel, P. Debourdeau, G. Robert, Arnauld Villers, Guillaume Ploussard, Benjamin Pradère, F. Bruyère, Jean‐Luc Descotes, Idir Ouzaïd, Alexander Winter, Herbert Hanitzsch, H. Sperling, Ralf Eckert, Peter Hammerer, E. Stagge, F. Seseke, Silvio Szymula, Aristotelis Bamias, A. Thanos, Konstantinos Hatzimouratidis, Charalambos Mamoulakis, Haralabos P. Kalofonos, Elżbieta Oszukowska, Katarzyna Madziarska, Jacek Fijuth, Mateusz Obarzanowski, B. Yа. Alekseev, Vagif Atduev, Dmitri Pushkar, Evgeniy Veliev, A. V. Zyryаnov, С Б Петров, Evgeny Kopyltsov, Vadim Kozlov, Ladislav Macko, J. Dúbravický, Richard Polak, Obaidullah Mir, Marek Vargovcak, I. Minčík, J. Kliment, Frederico Gonçalves, J Mikuláš, Roman Sokol ほか 55 名 - Circulation 2021 被引用: 143

  14. Risk Factor Burden and Long‐Term Prognosis of Patients With Premature Coronary Artery Disease

    著者: , , , , , , , , , - Journal of the American Heart Association 2020 被引用: 161

  15. Targeting Vascular Calcification in Chronic Kidney Disease

    著者: , , , , , - JACC Basic to Translational Science 2020 被引用: 156

  16. Baseline Risk of Major Bleeding in Non–ST-Segment–Elevation Myocardial Infarction

    著者: , , , , , , , , , , , , - Circulation 2009 被引用: 991

  17. Effect of Alirocumab on Stroke in ODYSSEY OUTCOMES

    著者: , , , , , , , , , , , , , , , , , , - Circulation 2019 被引用: 130

  18. Study Design and Rationale of EXPLORER-HCM

    著者: , , , , , , , , , - Circulation Heart Failure 2020 被引用: 85

  19. Treatment Gaps in Adults With Heterozygous Familial Hypercholesterolemia in the United States

    著者: , , , , , , , , , , , , , , , , , , , , , , - Circulation Cardiovascular Genetics 2016 被引用: 226

  20. Impact of Regulatory Guidance on Evaluating Cardiovascular Risk of New Glucose-Lowering Therapies to Treat Type 2 Diabetes Mellitus

    著者: , , , , , , , , , , , , , , , , , , , , - Circulation 2020 被引用: 108

  21. Cardiovascular Drug Development

    著者: , , , , , , , , , , , , , , , , , , , , - Journal of the American College of Cardiology 2015 被引用: 204

  22. Long-Term Mortality of Patients Undergoing Cardiac Catheterization for ST-Elevation and Non-ST-Elevation Myocardial Infarction

    著者: , , , , , , , , - Circulation 2009 被引用: 253

  23. Alirocumab Reduces Total Nonfatal Cardiovascular and Fatal Events

    著者: , , , , , , , , , , , , , , , , , , , , , , , - Journal of the American College of Cardiology 2018 被引用: 172

  24. Comparative Efficacy and Safety of Oral P2Y 12 Inhibitors in Acute Coronary Syndrome

    著者: , , , , , , , , , , , , , , - Circulation 2020 被引用: 141